Boston Scientific has announced the inclusion of two devices in this year’s NHS MedTech Funding Mandate (MTFM) policy.
The GreenLight XPS Laser Therapy System and Rezūm Water Vapor Therapy System treat benign prostatic hyperplasia – also known as benign prostatic hyperplasia (BPH) – a common condition that describes a enlarged prostate and usually affects men over 50. It is currently estimated that up to three million men in the UK have lower urinary tract symptoms associated with BPH.
The MedTech Funding Mandate was introduced to accelerate the uptake of certain cost-effective medical devices, diagnostics and digital products in the NHS, meaning patients should have access to these technologies more quickly. Each product or device must also have been reviewed by the National Institute for Health and Care Excellence (NICE), which GreenLight Laser Therapy and Rezūm Water Vapor Therapy were in 2016 and 2020, respectively, and demonstrate cost savings within one year.
Previously, treatment for BPH included either medication, which requires daily use, or surgery, such as transurethral resection of the prostate (known as TURP), which could mean having to stay in hospital for up to three days. Alternative treatment options such as the GreenLight XPS System and the Rezūm System can be performed in a shorter time frame than traditional treatment such as TURP, and patients can receive treatment and go home the same day. It also has less impact on NHS costs and the environment; it is estimated that up to 13 kg of total waste is generated per patient per day in the hospital.
Symptoms of BPH can include frequent urination with multiple trips to the bathroom during the night and difficulty completely emptying the bladder. In some men, the symptoms are mild, but others are more severely affected.
Charles Ellis said: “As you get older things get harder and who wants anything gets in the way of their quality of life, especially when you love what you do and want to keep doing it. Around the age of 52, I started needing to go to the bathroom more often and found myself quite distressed that I couldn’t find one easily. I heard about water vapor therapy on the radio and after doing my own research, I had the treatment done. I’m really happy now – I don’t have to think about whether there’s a toilet nearby all the time.
The GreenLight XPS system works by using a laser to rapidly heat and then vaporize excess prostate tissue. The Rezum system differs in that it delivers small amounts of vapor to the enlarged prostate; this damages the cells responsible for the obstruction and reduces the size of the prostate.
Miguel Aragon, Vice President, Urology and Pelvic Health, Boston Scientific, said, “We are thrilled and proud that GreenLight and Rezum have been included in the MedTech funding mandate for 2022-23, which is great news for many men in the UK who experience debilitating and sometimes embarrassing symptoms of BPH. Additionally, GreenLight and Rezum provide long-lasting symptom relief, patients generally require only a short hospital stay, and most men are back to their regular activities within days.